Startup Diligence
Latest private-market research

Startup diligence,
written by AI.

Each report runs end-to-end research on a private startup and writes it up like an investment committee memo: cover snapshot, executive summary, market sizing, competitors, financials, product, customers, risks, and valuation. Every claim links to a public source.

Latest reports

Newest generated reports first. Top-rated rankings live on their own page.

View archive
digital health / telepsychiatry late-stage venture (Series D)

Talkiatry

Talkiatry is the category-leading in-network telepsychiatry provider group with 800+ employed psychiatrists and 3M+ visits, but opaque unit economics, fixed W-2 labor costs, and DEA/regulatory exposure keep it a research-more name.

Research more Stretched Risk: High
Cybersecurity / Quantum AI Late-stage private

SandboxAQ

SandboxAQ remains a technically credible quantitative-AI platform with marquee government traction and elite backing, but its $5.75 billion valuation still outpaces disclosed fundamentals.

Track Stretched Risk: High
Valuation
$5.8B
Infrastructure / DevTools (Enterprise Networking-as-a-Service) Series C

Meter

Meter has a credible full-stack networking product and real customer proof, but the current ~$1B mark is hard to underwrite without revenue, margin, and concentration data.

Research more Stretched Risk: High
Valuation
$1B
fintech late-stage venture

Kikoff

Kikoff has meaningful consumer reach and a differentiated low-cost credit-building bundle, but the public record still leaves retention, unit economics, and servicing quality too opaque to justify the headline valuation with conviction.

Research more Stretched Risk: High
Valuation
$1B
Public safety technology / surveillance Late-stage private / Series H

Flock Safety

Flock Safety is a scaled public-safety platform with a nationwide network and strong venture backing, but opaque unit economics and growing legal and municipal backlash keep the right call at TRACK.

Track Stretched Risk: High
Valuation
$8.3B
ARR
$300M
Growth
70%
consumer / proptech late-stage venture

EliseAI

EliseAI's dominant multifamily footprint and $200M+ ARR support a Buy, but the $4B valuation and private compliance and unit-economics gaps keep the thesis stretched and high risk.

Buy Stretched Risk: High
Valuation
$4B
ARR
$200M
Growth
100%
RF intelligence / defense technology Public

HawkEye 360

HawkEye 360 is a differentiated public RF-intelligence franchise with strong revenue growth, backlog visibility, and post-IPO liquidity, but heavy federal-customer concentration, opaque unit economics, and a still-stretched valuation keep it in track territory.

Track Stretched Risk: High
Valuation
$1.4B
Revenue run-rate
$217.5M
Growth
87%
Embodied AI / Humanoid Robotics Series B+

Galaxea AI

Galaxea AI shows real embodied-AI technical momentum and early customer reach, but opaque economics and a stretched private valuation keep the right stance at track.

Track Stretched Risk: High
Valuation
$2.9B
AI infrastructure Series A

TypeSafe AI

TypeSafe AI has a differentiated structured-decision product and real launch momentum, but the $7.5B price leaves little room for error without audited revenue and retention proof.

Research more Expensive Risk: High
Valuation
$7.5B
Consumer / Gaming (AAA Video Games) Private, post-launch franchise scale-up

Game Science

Game Science proved unmatched commercial velocity and production efficiency with Black Myth: Wukong, but single-franchise revenue concentration and Tencent private shareholding warrant a disciplined research-more posture.

Research more Fair Risk: High
Climate / Energy Pre-commercial private

Energy Exploration Technologies, Inc. (EnergyX)

EnergyX has genuine strategic backing and DLE technical progress, but the company still lacks commercial-scale operating proof and binding project finance, so the public record supports TRACK with high risk.

Track Stretched Risk: High
Valuation
$3.3B
Capital markets technology Series E

Capitolis

Capitolis is strategically relevant infrastructure for large banks, but the $1.9 billion mark is not fully underwritten because core economics and acquisition terms remain private.

Research more Stretched Risk: High
Valuation
$1.9B

Showing 12 of 1,421 reports.

See all 1,421 reports →